Clinical Expression Line
Compugen Discovers Drug Target For Treatment Of Epithelial Tumors
Compugen Ltd., announced recently the discovery and experimental validation of CGEN-671, a new drug target for multiple epithelial tumors. CGEN-671 is a membrane splice variant of CD55, a known drug target for gastric cancer for which monoclonal antibody (mAb) therapeutics are in clinical development by others. The potential application of CGEN-671 as a drug target was initially predicted in ...
For More Clinical Expression Line Info Click On The Blue Links Below

Many thanks for reading our Clinical Expression Line article